BRUSSELS: The European Fee desires to succeed in a take care of Moderna for the availability of tens of millions of doses of its COVID-19
vaccine candidate for a worth beneath $25 per dose, an EU official concerned within the talks mentioned.
Moderna mentioned on Monday its experimental vaccine was 94.5% efficient in stopping COVID-19, primarily based on interim knowledge from a late-stage scientific trial. The EU has been in talks with Moderna for its experimental COVID-19 vaccine at the least since July, an inner EU doc seen by Reuters reveals.
Disclaimer: This submit has been auto-published from an company feed with none modifications to the textual content and has not been reviewed by an editor